Overview
Shiro Fujita practices in Kobe, Japan. Mr. Fujita is rated as an Experienced expert by MediFind in the treatment of Paronychia. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, and EGFR Positive Lung Cancer.
His clinical research consists of co-authoring 94 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Paronychia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerMr. Fujita isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Fujita isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- EGFR Positive Lung CancerMr. Fujita isAdvanced. Learn about EGFR Positive Lung Cancer.
- Squamous Cell Lung CarcinomaMr. Fujita isAdvanced. Learn about Squamous Cell Lung Carcinoma.
- Experienced
- Acute Interstitial PneumoniaMr. Fujita isExperienced. Learn about Acute Interstitial Pneumonia.
- Febrile NeutropeniaMr. Fujita isExperienced. Learn about Febrile Neutropenia.
- HemangioendotheliomaMr. Fujita isExperienced. Learn about Hemangioendothelioma.
- Hepatic Venoocclusive Disease with Immunodeficiency
- Interstitial Lung DiseaseMr. Fujita isExperienced. Learn about Interstitial Lung Disease.
- Lung AdenocarcinomaMr. Fujita isExperienced. Learn about Lung Adenocarcinoma.